These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16848312)

  • 1. [Advances in the study of glucokinase and small molecule glucokinase activators].
    Li YQ; Feng ZQ; Song HR; Guo YS; Guo ZR
    Yao Xue Xue Bao; 2006 May; 41(5):390-4. PubMed ID: 16848312
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in glucokinase activators for the treatment of type 2 diabetes.
    Pal M
    Drug Discov Today; 2009 Aug; 14(15-16):784-92. PubMed ID: 19520181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel glucokinase activators: a patent review (2008 - 2010).
    Sarabu R; Berthel SJ; Kester RF; Tilley JW
    Expert Opin Ther Pat; 2011 Jan; 21(1):13-33. PubMed ID: 21155690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
    Xu J; Lin S; Myers RW; Addona G; Berger JP; Campbell B; Chen HS; Chen Z; Eiermann GJ; Elowe NH; Farrer BT; Feng W; Fu Q; Kats-Kagan R; Kavana M; Malkani S; McMasters DR; Mitra K; Pachanski MJ; Tong X; Trujillo ME; Xu L; Zhang B; Zhang F; Zhang R; Parmee ER
    Bioorg Med Chem Lett; 2017 May; 27(9):2069-2073. PubMed ID: 28284804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus.
    Park K; Lee BM; Hyun KH; Lee DH; Choi HH; Kim H; Chong W; Kim KB; Nam SY
    Bioorg Med Chem; 2014 Apr; 22(7):2280-93. PubMed ID: 24588963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Salicylic acid derivatives as simplified and novel GK small molecule activators].
    Huo LC; Zhang YL; Lei L; Liu SN; Shen ZF; Wang YL; Song HR; Feng ZQ
    Yao Xue Xue Bao; 2013 Apr; 48(4):514-20. PubMed ID: 23833938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of N-thiazol-2-yl benzamide as glucokinase activators: Impacts of glutathione trapping on covalent binding.
    Iino T; Hashimoto N; Hasegawa T; Chiba M; Eiki J; Nishimura T
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1619-22. PubMed ID: 20138764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and SAR of novel glucokinase activators.
    Cheruvallath ZS; Gwaltney SL; Sabat M; Tang M; Feng J; Wang H; Miura J; Guntupalli P; Jennings A; Hosfield D; Lee B; Wu Y
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2166-71. PubMed ID: 23434031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic properties of the glucokinase activator MK-0941 in rodent models of type 2 diabetes and healthy dogs.
    Eiki J; Nagata Y; Futamura M; Sasaki-Yamamoto K; Iino T; Nishimura T; Chiba M; Ohyama S; Yoshida-Yoshimioto R; Fujii K; Hosaka H; Goto-Shimazaki H; Kadotani A; Ohe T; Lin S; Langdon RB; Berger JP
    Mol Pharmacol; 2011 Dec; 80(6):1156-65. PubMed ID: 21937665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides: discovery of PSN-GK1.
    Bertram LS; Black D; Briner PH; Chatfield R; Cooke A; Fyfe MC; Murray PJ; Naud F; Nawano M; Procter MJ; Rakipovski G; Rasamison CM; Reynet C; Schofield KL; Shah VK; Spindler F; Taylor A; Turton R; Williams GM; Wong-Kai-In P; Yasuda K
    J Med Chem; 2008 Jul; 51(14):4340-5. PubMed ID: 18588279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new class of glucokinase activators through structure-based design.
    Hinklin RJ; Boyd SA; Chicarelli MJ; Condroski KR; DeWolf WE; Lee PA; Lee W; Singh A; Thomas L; Voegtli WC; Williams L; Aicher TD
    J Med Chem; 2013 Oct; 56(19):7669-78. PubMed ID: 24015910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of 3,5-disubstituted benzamides as glucokinase activators with potent in vivo efficacy.
    Iino T; Hashimoto N; Sasaki K; Ohyama S; Yoshimoto R; Hosaka H; Hasegawa T; Chiba M; Nagata Y; Eiki J; Nishimura T
    Bioorg Med Chem; 2009 Jun; 17(11):3800-9. PubMed ID: 19427223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicine. Drug deals diabetes a one-two punch.
    Couzin J
    Science; 2003 Jul; 301(5631):290. PubMed ID: 12869732
    [No Abstract]   [Full Text] [Related]  

  • 14. Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675).
    Haynes NE; Corbett WL; Bizzarro FT; Guertin KR; Hilliard DW; Holland GW; Kester RF; Mahaney PE; Qi L; Spence CL; Tengi J; Dvorozniak MT; Railkar A; Matschinsky FM; Grippo JF; Grimsby J; Sarabu R
    J Med Chem; 2010 May; 53(9):3618-25. PubMed ID: 20405948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a potent, soluble glucokinase activator with increased pharmacokinetic half-life.
    Pike KG; Allen JV; Caulkett PW; Clarke DS; Donald CS; Fenwick ML; Johnson KM; Johnstone C; McKerrecher D; Rayner JW; Walker RP; Wilson I
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3467-70. PubMed ID: 21515051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.
    Matschinsky FM; Zelent B; Doliba NM; Kaestner KH; Vanderkooi JM; Grimsby J; Berthel SJ; Sarabu R
    Handb Exp Pharmacol; 2011; (203):357-401. PubMed ID: 21484579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric activators of glucokinase: potential role in diabetes therapy.
    Grimsby J; Sarabu R; Corbett WL; Haynes NE; Bizzarro FT; Coffey JW; Guertin KR; Hilliard DW; Kester RF; Mahaney PE; Marcus L; Qi L; Spence CL; Tengi J; Magnuson MA; Chu CA; Dvorozniak MT; Matschinsky FM; Grippo JF
    Science; 2003 Jul; 301(5631):370-3. PubMed ID: 12869762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule glucokinase activators as novel anti-diabetic agents.
    Leighton B; Atkinson A; Coghlan MP
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):371-4. PubMed ID: 15787609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose modulation of glucokinase activation by small molecules.
    Ralph EC; Thomson J; Almaden J; Sun S
    Biochemistry; 2008 Apr; 47(17):5028-36. PubMed ID: 18370405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Activity Relationship of Azaindole-Based Glucokinase Activators.
    Paczal A; Bálint B; Wéber C; Szabó ZB; Ondi L; Theret I; De Ceuninck F; Bernard C; Ktorza A; Perron-Sierra F; Kotschy A
    J Med Chem; 2016 Jan; 59(2):687-706. PubMed ID: 26685731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.